What is Nektar Therapeutics's change in AP?

Nektar Therapeutics (NKTR) reported change in AP of -$934K in Q1 2026.

How has Nektar Therapeutics's change in AP changed year-over-year?

Nektar Therapeutics's change in AP decreased by 114.6% year-over-year, from $6.41M to -$934K.

What is the long-term trend for Nektar Therapeutics's change in AP?

Over 3 years (2021 to 2025), Nektar Therapeutics's change in AP has grown at a -62.3% compound annual growth rate (CAGR), from -$11.69M to -$625K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Nektar Therapeutics NKTR Change in AP

Change in AP at other companies

AmgenAMGN

$571M+14.9%

Regeneron PharmaceuticalsREGN

$107.7M+150%

ImmunityBio, Inc.IBRX

$3.9M-39.4%

Apogee Therapeutics, Inc.APGE

$16K-98.8%

ImmunomeIMNM

$1.42M+137%

Vera TherapeuticsVERA

-$7.97M-599%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's change in AP?: Nektar Therapeutics (NKTR) reported change in AP of -$934K in Q1 2026.
How has Nektar Therapeutics's change in AP changed year-over-year?: Nektar Therapeutics's change in AP decreased by 114.6% year-over-year, from $6.41M to -$934K.
What is the long-term trend for Nektar Therapeutics's change in AP?: Over 3 years (2021 to 2025), Nektar Therapeutics's change in AP has grown at a -62.3% compound annual growth rate (CAGR), from -$11.69M to -$625K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.